Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Wearable Health Solutions's Debt-to-EBITDA or its related term are showing as below:
WHSI's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.62 * Ranked among companies with meaningful Debt-to-EBITDA only.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Wearable Health Solutions Debt-to-EBITDA Related Terms
Wearable Health Solutions Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WHSI vs SNAL, GDEV, GRVY: Debt-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Wearable Health Solutions's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wearable Health Solutions Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Wearable Health Solutions's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Wearable Health Solutions's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.
Wearable Health Solutions (WHSI) has a Debt-to-EBITDA of 3.47 as of Dec. 2023. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Wearable Health Solutions.
Is Wearable Health Solutions' Debt-to-EBITDA too high?
Wearable Health Solutions' current Debt-to-EBITDA is 3.47. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.62. Wearable Health Solutions' value of 3.47 is 114.2% above this industry median.
How does Wearable Health Solutions' Debt-to-EBITDA compare to SNAL and GDEV?
Wearable Health Solutions' Debt-to-EBITDA of 3.47 can be compared against companies in the Medical Devices & Instruments industry. The industry median Debt-to-EBITDA is 1.62. Wearable Health Solutions' value of 3.47 is 114.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.62, based on 469 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wearable Health Solutions's current Debt-to-EBITDA of 3.47 is 114.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Wearable Health Solutions. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wearable Health Solutions's current Debt-to-EBITDA is 3.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wearable Health Solutions stock overvalued right now?
Wearable Health Solutions (WHSI) has a current Debt-to-EBITDA of 3.47. The current Debt-to-EBITDA is 3.47 and 114.2% above the Medical Devices & Instruments industry median of 1.62. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Wearable Health Solutions (WHSI), the current Debt-to-EBITDA is 3.47 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wearable Health Solutions Inc is engaged in manufacturing medical alarm devices which are used to summon help in the event of an emergency. The company provides mobile health (mHealth) products and services to be used by customers in case of an emergency. As a provider of personal emergency devices, it provides wearable healthcare products, tracking services, and turn-key solutions that enable its users to be proactive with their health, as well as safe and protected.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WHSI has been successfully added to your 
